Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: A multi-institutional TriNetX study
{{output}}
Introduction: Women with type 2 diabetes mellitus (T2DM) have an increased risk of ovarian cancer. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) impact on the risk of ovarian cancer in women with T2DM remains unclear. Theref... ...
